Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 24
- Page suivante
| Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Concentré de recherche: Évaluation de la sécurité des pompes à perfusion pour les transfusions de globules rouges | Wolfe A | 2022 | Blood.ca website | View Concentré de recherche: Évaluation de la sécurité des pompes à perfusion pour les transfusions de globules rouges | Researchers | Benchmarking and standard setting |
| Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Thompson T, Callum J | 2022 | Ontario Regional Blood Coordinating Network February 2022 Newsletter | View Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Health care providers | Clinical research |
| Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study | Razatos A, Acker JP, de Korte D, Bégué S, Noorman F, Doyle B, Zia M, Min K, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study | Researchers | New or improved product or process |
| International Forum on the Management of Major Haemorrhage: Responses | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Responses | Health care providers | Benchmarking and standard setting |
| International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018 | Crowder LA, Wendel S, Bloch EM, O'Brien SF, Delage G, Sauleda S, Leiby DA, for the WP-TTID Subgroup on Parasites | 2022 | Vox Sang | View International survey of strategies to mitigate transfusion-transmitted Trypanosoma cruzi in non-endemic countries, 2016–2018 | Researchers | Benchmarking and standard setting |
| (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus | Almizraq RJ, Frias Boligan K, Loriamini M, McKerlie C, Branch DR | 2022 | Front Immunol | View (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus | Researchers | Basic research |
| Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH | 2022 | Blood Adv | View Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
| Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
| Evolving policies for donors with diabetes: The Canadian experience | Miller O, Caffrey N, O'Brien SF, Goldman M | 2022 | Vox Sang | View Evolving policies for donors with diabetes: The Canadian experience | Researchers | New or improved product or process |
| Chapter 17. Hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 17. Hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
| Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis | Vardaki MZ, Georg Schulze H, Serrano K, Blades MW, Devine DV, F. B. Turner R | 2022 | Spectrochim Acta A Mol Biomol | View Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis | Researchers | New or improved product or process |
| Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts | Kaushal R, Jahan S, McGregor C, Pineault N | 2022 | Cytotherapy | View Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts | Researchers | New or improved product or process |
| Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice | Afraz S, Stevic I, Matino D, Wen J, Atkinson H, Chan AKC, Hortelano G | 2022 | Sci Rep | View Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice | Researchers | Clinical research |
| FAQ : Test des titres d’iso-hémagglutinines (anti-A/anti-B) des donneurs à la Société canadienne du sang | Bodnar M, Bienz M, Clarke G | 2022 | Blood.ca website | View FAQ : Test des titres d’iso-hémagglutinines (anti-A/anti-B) des donneurs à la Société canadienne du sang | Health care providers | New or improved product or process |
| Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Jacquot C, Tiberghien P, van den Hurk K, Ziman A, Shaz B, Apelseth TO, Goldman M, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Blood donor eligibility criteria for medical conditions: A BEST collaborative study | Researchers | Benchmarking and standard setting |
| SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ | 2022 | Viruses | View SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | Researchers | Clinical research |
| Circular of information for the use of human blood components: Plasma Components | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
| The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Holloway K, Simms N, Hayeems RZ, Miller FA | 2022 | Hastings Cent Rep | View The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Regulators | Ethical, legal and social implications research |
| Complement contributions to COVID-19 | Conway EM, Pryzdial ELG | 2022 | Curr Opin Hematol | View Complement contributions to COVID-19 | Researchers | Basic research |
| Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Hahn B, Quee F, Prinsze FJ, Gregoire Y, O'Brien SF, Germain M, van de Laar T, Zaaijer HL, van den Hurk K | 2022 | Transfusion | View Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Blood operators | MSM research |
| Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y, Shao Y, Deng J, Ding H, Liu J, Wang J, Ni H, Fu Y, Santoso S | 2021 | Blood | View Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Researchers | Basic research |
| Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Strauss R, Menchetti I, Perrier L, Blondal E, Peng H, Sullivan-Kwantes W, Tien H, Nathens A, Beckett A, Callum J, da Luz LT | 2021 | Trauma Surg Acute Care Open | View Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Health care providers | Clinical research |
| Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Prokopchuk-Gauk O, Solh Z | 2021 | Guide de la pratique transfusionnelle | View Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Health care providers | Benchmarking and standard setting |
| SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM | 2021 | medRxiv | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Researchers | Clinical research |
| Concentré de recherche: Transfusion de plaquettes chez les enfants atteints de cancer | Barty R | 2021 | Blood.ca website | View Concentré de recherche: Transfusion de plaquettes chez les enfants atteints de cancer | Health care providers | Benchmarking and standard setting |
| A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O’Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
| American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, E AA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ | 2021 | Blood Adv | View American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Health care providers | Benchmarking and standard setting |
| Circulaire d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleucocyté (PD) | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
| Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells | Jahan S, Kaushal R, Pasha R, Pineault N | 2021 | Transfus Med Rev | View Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells | Researchers | New or improved product or process |
| SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system | Srivastava K, Albasri J, Alsuhaibani OM, Aljasem HA, Bueno MU, Antonacci T, Branch DR, Denomme GA, Flegel WA | 2021 | Transfusion | View SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system | Researchers | Basic research |
| Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Sholzberg M, Arnold DM, Laupacis A | 2021 | CMAJ | View Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Health care providers | Clinical research |
| Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Norris PAA, Kaur G, Khan R, Zhu G, Ni H, Lazarus AH | 2021 | Blood | View Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fc? receptor inhibition | Researchers | Basic research |
| Impact of COVID-19 on blood donation in Canada | Khandelwal A | 2021 | Blood.ca website | View Impact of COVID-19 on blood donation in Canada | Health care providers | Benchmarking and standard setting |
| Transfusion-related acute lung injury (TRALI) | Gupta A, Yan M | 2021 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Health care providers | Benchmarking and standard setting |
| Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Khayyat H, Callum JL, Hill-Strathy M, Strauss R, Notario L, Nathens A, da Luz L | 2021 | Can J Anaesth | View Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Health care providers | Clinical research |
| Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety | Blumenstein I, Shanbhag S, Langguth P, Kalra PA, Zoller H, Lim W | 2021 | Expert Opin Drug Saf | View Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety | Researchers | Basic research |
| Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Vijenthira S, Armali C, Downie H, Wilson A, Paton K, Berry B, Wu HX, Robitaille A, Cserti-Gazdewich C, Callum J | 2021 | Vox Sang | View Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Health care providers | Clinical research |
| Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Kron A | 2021 | Blood.ca website | View Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Health care providers | Clinical research |
| Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Haw J, Thorpe R, Holloway K | 2021 | SocArXiv | View Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Blood operators | Ethical, legal and social implications research |
| COVID-19 Case Age Distribution: Correction for Differential Testing by Age | Fisman DN, Greer A, Brankston G, Hillmer M, O'Brien SF, Drews S, Tuite AR | 2021 | Ann Intern Med | View COVID-19 Case Age Distribution: Correction for Differential Testing by Age | Researchers | Clinical research |
| Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial | Alshahrani MS, AlSulaibikh AH, ElTahan MR, AlFaraj SZ, Asonto LP, AlMulhim AA, AlAbbad MF, Almaghraby N, AlJumaan MA, AlJunaid TO, Darweesh MN, AlHawaj FM, Mahmoud AM, Alossaimi BK, Alotaibi SK, AlMutairi TM, AlSulaiman Pharm DD, Alfaraj D, Alhawwas R, Mbuagbaw L, Lewis K, Verhovsek M, Crowther M, Guyatt G, Alhazzani W | 2021 | Acad Emerg Med | View Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial | Researchers | Clinical research |
| A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis | Pendergrast J, Armali C, Callum J, Cserti-Gazdewich C, Jiwajee A, Lieberman L, Lau W, Lin Y, Parmar N, Pavenski K, Riden LS, Shehata N, Willie-Ramharack K, Tomlinson G, Tong TN, Binnington B, Branch DR | 2021 | Transfusion | View A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis | Researchers | Clinical research |
| Tantalum-containing mesoporous bioactive glass powder for hemostasis | Nagrath M, Gallant R, Yazdi AR, Mendonca A, Rahman S, Chiu L, Waldman SD, Ni H, Towler MR | 2021 | J Biomater Appl | View Tantalum-containing mesoporous bioactive glass powder for hemostasis | Researchers | Basic research |
| Genome Sequence of Staphylococcus aureus Strain PS/BAC/317/16/W, Isolated from Contaminated Platelet Concentrates in England | Yousuf B, Flint A, Weedmark K, McDonald C, Bearne J, Pagotto F, Ramirez-Arcos S, Hotopp JCD | 2021 | Microbiol Resour Announc | View Genome Sequence of Staphylococcus aureus Strain PS/BAC/317/16/W, Isolated from Contaminated Platelet Concentrates in England | Researchers | Benchmarking and standard setting |
| Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 | Thiele T, Ulm L, Holtfreter S, Schönborn L, Kuhn SO, Scheer C, Warkentin TE, Bröker BM, Becker K, Aurich K, Selleng K, Hübner N-O, Greinacher A | 2021 | Blood | View Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 | Researchers | Clinical research |
| Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group | Ray JG, Warkentin TE, Park AL | 2021 | Thromb Res | View Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group | Researchers | Clinical research |
| Staphylococcus epidermidis undergoes global changes in gene expression during biofilm maturation in platelet concentrates | Loza-Correa M, Yousuf B, Ramirez-Arcos S | 2021 | Transfusion | View Staphylococcus epidermidis undergoes global changes in gene expression during biofilm maturation in platelet concentrates | Researchers | Basic research |
| Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells | Jahan S, Kaushal R, Pasha R, Pineault N | 2021 | Transfus Med Rev | View Current and Future Perspectives for the Cryopreservation of Cord Blood Stem Cells | Researchers | New or improved product or process |
| Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score | COVIDSurg Collaborative | 2021 | Br J Surg | View Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score | Health care providers | Benchmarking and standard setting |
| COVID-19 convalescent plasma: Interim recommendations from the AABB | Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR | 2021 | Transfusion | View COVID-19 convalescent plasma: Interim recommendations from the AABB | Health care providers | Clinical research |